Vivid Microscopy

Vivid Microscopy

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.2M

Overview

Vivid Microscopy is an early-stage biotech firm commercializing patented fluorescent probes for detecting oxidative stress in live cells. Its core products, SEMKUR-imaging and SEMKUR-cell sorting, are marketed as research tools for the life sciences, with applications in areas like cardiovascular disease, toxicology, and aging. The company is actively collaborating with academic institutions for validation and is developing next-generation probes for quantitative analysis.

Diagnostics

Technology Platform

Patented dithiol-based fluorescent probes for imaging and sorting live cells based on oxidative stress levels.

Funding History

1
Total raised:$3.2M
Seed$3.2M

Opportunities

The growing focus on redox biology in aging, neurodegeneration, and cardiometabolic disease research creates a expanding market for sensitive, live-cell analysis tools.
The ability to sort cells based on oxidative stress opens unique applications in studying heterogeneous cell populations, such as senescent cells or cancer stem cells.

Risk Factors

Intense competition from large, established life science reagent companies with broader portfolios and greater sales reach.
Risk of slow adoption if the probes are not perceived as a significant improvement over existing, potentially cheaper methods.
Reliance on academic collaborations for critical validation data introduces dependency.

Competitive Landscape

Vivid competes in the oxidative stress assay market against major players like Thermo Fisher (e.g., CellROX, MitoSOX dyes), Abcam, and Merck, as well as numerous smaller specialty reagent firms. Its differentiation lies in its patented dithiol chemistry, reversible binding, and dual utility for imaging and cell sorting, but it must overcome the strong brand loyalty and convenience of incumbent solutions.